These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5033189)

  • 1. Altered antigenicity in spontaneous pulmonary metastases from an antigenic murine sarcoma.
    Sugarbaker EV; Cohen AM
    Surgery; 1972 Jul; 72(1):155-61. PubMed ID: 5033189
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro demonstration of altered antigenicity of metastases from a primary methylcholanthrene-induced sarcoma.
    Faraci RP
    Surgery; 1974 Sep; 76(3):469-73. PubMed ID: 4852382
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation isoantigenicity of a rat sarcoma and its spontaneous metastases.
    Proctor JW; Palmer P; Rudenstam CM
    J Natl Cancer Inst; 1974 Aug; 53(2):579-80. PubMed ID: 4135600
    [No Abstract]   [Full Text] [Related]  

  • 4. A factor preventing the development of lung metastases in rats with sarcomas.
    Proctor JW; Rudenstam CM; Alexander P
    Nature; 1973 Mar; 242(5392):29-31. PubMed ID: 4694291
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of immune status on the development of artificially induced metastases in different anatomical locations.
    Vaage J; Chen K; Merrick S
    Cancer Res; 1971 May; 31(5):496-500. PubMed ID: 5582111
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pulmonary metastasization and allotransplantability (murine sarcoma caused by methylcholanthrene)].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1968; 28(3):129-44. PubMed ID: 5733978
    [No Abstract]   [Full Text] [Related]  

  • 7. [The immunotherapeutic effect of partially purified tumor specific transplantation antigen against pulmonary metastasis].
    Inaba S; Tanaka T; Yamagishi H; Kobayashi M; Tsuchiya K; Oka T
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2273-8. PubMed ID: 6533208
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation or suppression of metastases with graded doses of tumor cells.
    Vanwijck RR; Godrick EA; Smith HG; Goldweitz J; Wilson RE
    Cancer Res; 1971 Nov; 31(11):1559-63. PubMed ID: 5121660
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity.
    Haywood GR; McKhann CF
    J Exp Med; 1971 Jun; 133(6):1171-87. PubMed ID: 5576331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.
    Oth D; Donner M; Burg C
    Transplantation; 1969 Nov; 8(5):742-5. PubMed ID: 5403331
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific active immunotherapy of murine methylcholanthrene-induced sarcoma using a partially purified soluble tumor specific transplantation antigens].
    Tanaka T; Yamagishi H; Inaba S; Kobayashi M; Kurioka H; Naito K; Hashimoto I
    Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):282-94. PubMed ID: 6201713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologically-mediated restraint of latent tumour metastases.
    Eccles SA; Alexander P
    Nature; 1975 Sep; 257(5521):52-3. PubMed ID: 1080544
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spontaneous metastasising of a methylcholanthrene induced sarcoma in animals with intact respective reduced immune reactivity].
    Boeryd B; Hagmar B; Suurküla M
    Nord Med; 1970 Nov; 84(45):1440. PubMed ID: 5481053
    [No Abstract]   [Full Text] [Related]  

  • 16. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro immunization against tumour-associated antigen of methylcholanthrene-induced sarcoma.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1978; 24(2):118-27. PubMed ID: 658547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene.
    Bloom ET
    J Natl Cancer Inst; 1970 Sep; 45(3):443-53. PubMed ID: 5523193
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous shedding of TSTA by viable sarcoma cells: its possible role in facilitating metastatic spread.
    Currie GA; Alexander P
    Br J Cancer; 1974 Jan; 29(1):72-5. PubMed ID: 4820948
    [No Abstract]   [Full Text] [Related]  

  • 20. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas.
    Proctor JW; Rudenstam CM; Alexander P
    J Natl Cancer Inst; 1974 Dec; 53(6):1671-6. PubMed ID: 4373575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.